期刊文献+

4种市售拉米夫定片主要质量指标的比较 被引量:9

The quality comparison of lamivudine tablets supplied by four manufactories
原文传递
导出
摘要 目的:对临床上使用的4个厂家生产的拉米夫定片(100 mg/片)进行主要质量指标的比较。方法:采用高效液相色谱法C18色谱柱测定拉米夫定片的主药含量、溶出度、有关物质,采用高效液相色谱法环糊精手性柱测定其右旋体。结果:4种片剂的主药含量均>90%,分别为97.74%,96.31%,93.74%和92.21%,以国产品种"银丁"最高。在pH 6.8磷酸盐缓冲液和去离子水中,10 min内4种片剂均完全溶出;在0.1 N盐酸和pH 4.5醋酸盐缓冲液中,包括"银丁"在内的3个产品在10 min内完全溶出,只有1个产品分别在15和30 min完全溶出。4种市售拉米夫定片剂中的有关物质及右旋体均符合美国药典34版中对该药原料的相关限度要求(0.6%和0.3%),其中"银丁"最低,分别为0.063%和0.023%。结论:4种市售拉米夫定片剂的主要质量指标均符合规定,但在含量、有关物质及右旋体等指标上有一定差异,国产品种"银丁"质量控制相对更为严格。 Objective:To compare the qualities of 4 kinds of lamivudine tablets(100mg) supplied by different manufactories.Methods:The content of lamivudine,related substances and dissolution were determined by HPLC with C18 column,and lamivudine enantiomer was determined by HPLC with cyclodextrin chiral column.Results:The contents of all lamivudine tablets were more than 90%,i.e.97.74%,96.31%,93.74% and 92.21%,respectively,among which the domestic product"Yinding" had the highest content.Complete dissolution was observed in pH 6.8 phosphate buffer and distilled water within 10 min for all of the 4 lamivudine tablets.In 0.1 N HCl and pH 4.5 acetate buffer,complete dissolution was reached in 10 min for 3 products including "Yingding",but for another product,the dissolution was not complete until 15 min and 30 min,respectively.The contents of related substances and enantiomer of all the tablets were lower than the limits specified in the drug monograph of USP 34 edition(0.6% and 0.3%),and the lowest contents were found for Yinding,which were 0.063% and 0.023%,respectively.Conclusion:The main quality items of lamivudine tablets produced by different companies all comply with the quality standard,but there exists variation.It seems that the quality was more strictly controlled by the manufacture of domestic product "Yingding".
出处 《中国新药杂志》 CAS CSCD 北大核心 2012年第8期931-935,共5页 Chinese Journal of New Drugs
关键词 拉米夫定 含量 溶出度 右旋体 高效液相色谱法 lamivudine content dissolution enantiomer HPLC
  • 相关文献

参考文献8

  • 1刁雨辉,刘文一,周建平.拉米夫定片质量比较研究和评价[J].药学与临床研究,2011,19(3):220-223. 被引量:7
  • 2李萌,刘有平,鲁静,邸欣.RP-HPLC法测定拉米夫定的含量及有关物质[J].药物分析杂志,2009,29(7):1216-1219. 被引量:7
  • 3吴意红,张丹,毛惠英,唐丽红.HPLC测定拉米夫定中的右旋异构体[J].华西药学杂志,2009,24(1):80-81. 被引量:3
  • 4董艳梅,周汉高.拉米夫定的药理与临床研究进展[J].中国综合临床,2001,17(1):8-10. 被引量:8
  • 5The United States Pharmacopoeial Convention.United States Phar-macopoeia34th.ed[]..2011
  • 6J. W. Beach,L. S. Jeong,A. J. Alves,D. Pohl,H. O. Kim,C. N. Chang,S. L. Doong,R. F. Schinazi,Y.-C. Cheng,C. K. Chu.Synthesis of Enantiomerically Pure (2R,5S)-(?)-1-(2-hydroxymethyl-L-oxathiolan-5-yl) cytosine as a Potent Antiviral Agent against Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV)[].Journal of Organic Chemistry.1992
  • 7Humber DC,Jones MF,Payne JJ,et al.Expeditious preparation of ( - )-2′-deoxy-3′-thiacyti-dine ( 3TC)[].Tetrahedron Letters.1992
  • 8Heathcote J,Schalm SW,Cianciara J,et al.Lamivudine and Intron A combination treatment in patients with chronic hepatitis B infection[].Hepatology.1998

二级参考文献26

  • 1梁晓峰,陈园生,王晓军,贺雄,陈丽娟,王骏,林长缨,白呼群,严俊,崔钢,于竞进.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志,2005,26(9):655-658. 被引量:967
  • 2丁晓萍,陈坚,熊海江.光纤药物溶出/释放度原位过程监测仪监测甲硝唑口腔粘贴片释放过程[J].药物分析杂志,2006,26(3):355-357. 被引量:1
  • 3吕卫红,方鹏飞.慢性乙型肝炎的抗病毒治疗进展[J].医药导报,2006,25(5):444-447. 被引量:13
  • 4Dutta T,Jain NK. Targeting potential and anti - HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer [ J]. Biochimica et Biophysica Acta,2007,1770:681 - 686.
  • 5Beach JW, Jeong LS, Alves AJ,et al. Synthesis of enantiomerically pure (2'R , 5'S ) - ( - ) -1 - [ 2 - ( hydroxy-methyl)oxathiolan - 5 - yl] cytosine as a potent antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus ( HIV ) [J].JOrgChem, 1992 ,57 (8) :2217 -2219.
  • 6Humber DC, Jones MF, Payne JJ, et al. Expeditious preparation of ( - ) - 2' - deoxy - 3' - thiacytidine (3TC) [ J]. Tetrahedron Lett , 1992 ,33 (32) :4625 - 4648.
  • 7USP30 - NF25. 2447.
  • 8BP. 2007. 2217.
  • 9Gerald G, Martin GS. Chiral separations methods and protocols [M]. numana Press ,2003.84 - 85.
  • 10Mario Rizzetto, Alfredo Marzano, Marco Lagget. Treatment of hepatitis B eantigen - negative chronic hepatitis B with lamivudine. J Hepatol, 2003,39( Supplement 1 ) : 168.

共引文献20

同被引文献47

引证文献9

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部